UK MHRA No-Deal Proposal Must Be Carefully Managed, UK Medtech Industry Leader Warns
Executive Summary
Questions still remain related to the recent technical notices and consultations from UK MHRA on the effects of a no-deal Brexit. Association of British Healthtech Industries' Phil Brown offers pointers as interested parties prepare to respond the consultations, which have a November 1 deadline.